Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

1.

Phase Ib study of dovitinib in combination with gemcitabine plus cisplatin or gemcitabine plus carboplatin in patients with advanced solid tumors.

Galsky MD, Posner M, Holcombe RF, Lee KM, Misiukiewicz K, Tsao CK, Godbold J, Soto R, Gimpel-Tetra K, Lowe N, Oh WK.

Cancer Chemother Pharmacol. 2014 Jul 15. [Epub ahead of print]

PMID:
25023489
[PubMed - as supplied by publisher]
2.

A novel signaling pathway regulates colon cancer angiogenesis through Norrin.

Planutis K, Planutiene M, Holcombe RF.

Sci Rep. 2014 Jul 9;4:5630. doi: 10.1038/srep05630.

PMID:
25005225
[PubMed - in process]
Free PMC Article
3.

Cancer Clinical Research: Return on Investment in the Era of Value-Based Purchasing.

Holcombe RF.

J Oncol Pract. 2014 Jun 17. pii: JOP.2014.001416. [Epub ahead of print] No abstract available.

PMID:
24939181
[PubMed - as supplied by publisher]
4.

Implementation of electronic chemotherapy ordering: an opportunity to improve evidence-based oncology care.

Adelson KB, Qiu YC, Evangelista M, Spencer-Cisek P, Whipple C, Holcombe RF.

J Oncol Pract. 2014 Mar;10(2):e113-9. doi: 10.1200/JOP.2013.001184. Epub 2013 Dec 26.

PMID:
24371301
[PubMed - in process]
Free Article
5.

Sweet's syndrome in a patient with metastatic melanoma after ipilimumab therapy.

Pintova S, Sidhu H, Friedlander PA, Holcombe RF.

Melanoma Res. 2013 Dec;23(6):498-501. doi: 10.1097/CMR.0000000000000017.

PMID:
24113862
[PubMed - indexed for MEDLINE]
6.

Correction: Granulocyte-macrophage stimulating factor (GM-CSF) increases circulating dendritic cells but does not abrogate suppression of adaptive cellular immunity in patients with metastatic colorectal cancer receiving chemotherapy.

Martinez M, Ono N, Planutiene M, Planutis K, Nelson EL, Holcombe RF.

Cancer Cell Int. 2013 Aug 15;13(1):80. doi: 10.1186/1475-2867-13-80. No abstract available.

PMID:
23945146
[PubMed]
Free PMC Article
7.

Invasive colon cancer, but not non-invasive adenomas induce a gradient effect of Wnt pathway receptor frizzled 1 (Fz1) expression in the tumor microenvironment.

Planutis K, Planutiene M, Nguyen AV, Moyer MP, Holcombe RF.

J Transl Med. 2013 Feb 26;11:50. doi: 10.1186/1479-5876-11-50.

PMID:
23442549
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Clinical pathways for pancreatic neuroendocrine tumors.

Alistar A, Sung M, Kim M, Holcombe RF.

J Gastrointest Cancer. 2012 Dec;43(4):532-40. doi: 10.1007/s12029-012-9397-y. Review.

PMID:
22661335
[PubMed - indexed for MEDLINE]
9.

Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancer.

Dellinger TH, Planutis K, Jandial DD, Eskander RN, Martinez ME, Zi X, Monk BJ, Holcombe RF.

Gynecol Oncol. 2012 Aug;126(2):259-67. doi: 10.1016/j.ygyno.2012.04.026. Epub 2012 Apr 30.

PMID:
22555103
[PubMed - indexed for MEDLINE]
Free PMC Article
10.
12.

Role of canonical Wnt signaling in endometrial carcinogenesis.

Dellinger TH, Planutis K, Tewari KS, Holcombe RF.

Expert Rev Anticancer Ther. 2012 Jan;12(1):51-62. doi: 10.1586/era.11.194. Review.

PMID:
22149432
[PubMed - indexed for MEDLINE]
13.

PR-104 plus sorafenib in patients with advanced hepatocellular carcinoma.

Abou-Alfa GK, Chan SL, Lin CC, Chiorean EG, Holcombe RF, Mulcahy MF, Carter WD, Patel K, Wilson WR, Melink TJ, Gutheil JC, Tsao CJ.

Cancer Chemother Pharmacol. 2011 Aug;68(2):539-45. doi: 10.1007/s00280-011-1671-3. Epub 2011 May 19.

PMID:
21594722
[PubMed - indexed for MEDLINE]
14.

A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202.

Iqbal S, Rankin C, Lenz HJ, Gold PJ, Ahmad SA, El-Khoueiry AB, Messino MJ, Holcombe RF, Blanke CD.

Cancer Chemother Pharmacol. 2011 Dec;68(6):1595-602. doi: 10.1007/s00280-011-1657-1. Epub 2011 May 10.

PMID:
21556747
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Wnt signaling and colon carcinogenesis: beyond APC.

Najdi R, Holcombe RF, Waterman ML.

J Carcinog. 2011 Mar 17;10:5. doi: 10.4103/1477-3163.78111.

PMID:
21483657
[PubMed]
Free PMC Article
16.

Mission-focused, productivity-based model for sustainable support of academic hematology/oncology faculty and divisions.

Holcombe RF, Hollinger KJ.

J Oncol Pract. 2010 Mar;6(2):74-9. doi: 10.1200/JOP.091075. Epub 2010 Feb 19.

PMID:
20592779
[PubMed]
Free PMC Article
17.

Differentiation of tubular and villous adenomas based on Wnt pathway-related gene expression profiles.

Nguyen AV, Albers CG, Holcombe RF.

Int J Mol Med. 2010 Jul;26(1):121-5.

PMID:
20514431
[PubMed - indexed for MEDLINE]
18.

A Wnt kinase network alters nuclear localization of TCF-1 in colon cancer.

Najdi R, Syed A, Arce L, Theisen H, Ting JH, Atcha F, Nguyen AV, Martinez M, Holcombe RF, Edwards RA, Marsh JL, Waterman ML.

Oncogene. 2009 Nov 26;28(47):4133-46. doi: 10.1038/onc.2009.271. Epub 2009 Sep 14.

PMID:
19749792
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells.

Tang Y, Simoneau AR, Liao WX, Yi G, Hope C, Liu F, Li S, Xie J, Holcombe RF, Jurnak FA, Mercola D, Hoang BH, Zi X.

Mol Cancer Ther. 2009 Feb;8(2):458-68. doi: 10.1158/1535-7163.MCT-08-0885. Epub 2009 Jan 27.

PMID:
19174556
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk